NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. The study was developed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI), part of the National Institutes of Health. ECOG-ACRIN is leading the trial.
TMIST researchers are enrolling healthy women ages 45 to 74 who are already planning to get routine mammograms. By taking part in TMIST, the 165,000 planned participants will provide critical information that will help researchers learn how to most effectively screen women for breast cancer and help women make informed decisions about the screening tests in the future.
How to join the TMIST mammography comparison study
For more information and a list of participating centers, see:
- NCI’s website: http://www.cancer.gov/TMIST
- ECOG-ACRIN’s website: http://www.ecog-acrin.org/TMIST
Read the Complete National Cancer Institute Press release: read more
Early detection is critical to beating cancer.
Walk-in-Lab provides a wide range of blood tests that can help you assess and improve your overall health and play a role in preventing cancer or its recurrence.
No doctor’s order is necessary and your confidential test results are available online.
Click the image above to review available health tests.
Robert Hess is an entrepreneur, business owner, CEO, senior executive coach, startup company advisor, and passionate cancer advocate. He is a 15+ year prostate cancer survivor dedicated to ending prostate cancer and helping cancer survivors have the possible possible quality of life. You can find him autocrossing or tracking his Mazda Miata, covered in cancer awareness messages; racing his Serenity in the velodrome; or walking and hiking with his wife. Earlier in life he had the honor of leading soldiers in the US Army – they even let him fly helicopters for a few years. Connect with him on LinkedIn @ RobertWarrenHess.
Leave a Reply